Bain Capital Life Sciences Investors LLC Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […]

Related Keywords

Alger ,Algeria ,Jack Anders ,Piper Sandler ,Raymond James ,Jeff Cislini ,Clear Harbor Asset Management ,Securities Exchange Commission ,Needham Company ,Hermes Inc ,Bain Capital Life Sciences Investors ,Fred Alger Management ,Mackenzie Financial Corp ,Nasdaq ,Manchester Capital Management ,Revolution Medicines Inc ,Revolution Medicines ,Free Report ,Capital Life Sciences Investors ,Capital Management ,Alger Management ,Harbor Asset Management ,General Counsel Jeff Cislini ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Revolution Medicines Daily ,